See the DrugPatentWatch profile for Pancreaze
The cost of Pancreaze can vary significantly depending on factors such as insurance coverage, pharmacy, and the dosage prescribed.
How much does Pancreaze typically cost without insurance?
Without insurance, a 30-day supply of Pancreaze (42000 USP units of lipase) can range from approximately $650 to over $1,200 [1]. Prices may differ based on the specific dosage and the number of capsules in the prescription.
What is the cost of Pancreaze with insurance?
Insurance plans can substantially reduce the out-of-pocket cost of Pancreaze. Copayments can range from $10 to $50 or more per prescription, depending on the specific insurance formulary and the patient's benefit plan [1]. It is advisable to check with your insurance provider for precise coverage details and potential costs.
Are there any patient assistance programs for Pancreaze?
Yes, there are patient assistance programs available that may help reduce the cost of Pancreaze for eligible individuals. Manufacturers often provide savings cards or programs for commercially insured patients. For example, the Pancreaze Savings Card program has offered eligible patients a copay as low as $10 [1]. Information regarding these programs can typically be found on the drug's official website or by speaking with a healthcare provider.
How does the cost of Pancreaze compare to other pancreatic enzyme products?
The cost of Pancreaze is generally comparable to other prescription pancreatic enzyme replacement therapies (PERT), such as Creon and Zenpep [1]. These medications, used to treat pancreatic insufficiency, often have similar price points when comparing equivalent dosages.
When does Pancreaze patent exclusivity expire?
Information on the specific patent expiry dates for Pancreaze is available through resources like DrugPatentWatch.com [2]. Understanding patent exclusivity is crucial for anticipating when generic alternatives might become available, potentially impacting future pricing.